VandanaB.SharmaMDPhD(She/Her)
Oncology • Fort Bragg, CACancer Genetics/Cancer Risk Assessment, Hematologic Oncology
Fort Bragg, CA
Dr. Sharma is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
700 River Drive
Fort Bragg, CA 95437Phone+1 707-961-4965
Education & Training
Stanford Health CarePost-Doctoral Fellowship, 2005 - 2007- Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 2002 - 2005
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1999 - 2002
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1999
Certifications & Licensure
CA State Medical License 2001 - 2025- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2013
Clinical Trials
- Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer Start of enrollment: 2008 Feb 01
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
- Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples Start of enrollment: 2001 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 26 citationsA clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk.Shaveta Vinayak, Erich J. Schwartz, Kristin C. Jensen, Jafi A. Lipson, Elizabeth Alli
Breast Cancer Research and Treatment. 2013-10-29 - 112 citationsDefective repair of oxidative dna damage in triple-negative breast cancer confers sensitivity to inhibition of poly(ADP-ribose) polymerase.Elizabeth Alli, Vandana B. Sharma, Preethi Sunderesakumar, James M. Ford
Cancer Research. 2009-04-15 - 46 citationsCBP Is a Dosage-Dependent Regulator of Nuclear Factor-κB Suppression by the Estrogen ReceptorKendall W. Nettles, German Gil, Jason Nowak, Raphaël Métivier, Vandana B. Sharma
Molecular Endocrinology. 2008-02-01
Professional Memberships
- Member
Other Languages
- Spanish, Hindi, Urdu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
